Neuphoria Therapeutics Inc.
NEUP · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $11,523 | $1,240,349 | $4,849,089 | $9,459,922 |
| - Cash | $14,210,745 | $12,608 | $8,056 | $23,090 |
| + Debt | $116,314 | $273 | $258 | $477 |
| Enterprise Value | -$14,082,908 | $1,228,013 | $4,841,290 | $9,437,309 |
| Revenue | $23,954 | $0 | $0 | $278 |
| % Growth | – | – | -100% | – |
| Gross Profit | $22,939 | -$993 | -$671 | $0 |
| % Margin | 95.8% | – | – | 0% |
| EBITDA | -$268 | -$22,331 | -$21,544 | -$28,027 |
| % Margin | -1.1% | – | – | -10,085.7% |
| Net Income | -$566 | -$23,193 | -$21,647 | -$22,936 |
| % Margin | -2.4% | – | – | -8,253.6% |
| EPS Diluted | -0.23 | -0.1 | -0.17 | -0.13 |
| % Growth | -130% | 41.2% | -30.8% | – |
| Operating Cash Flow | $77,229 | -$14,681 | -$9,846 | -$14,966 |
| Capital Expenditures | $0 | $0 | $0 | -$1 |
| Free Cash Flow | $77,229 | -$14,681 | -$9,846 | -$14,967 |